First-pass extracted concept

chronic chemogenetic toolbox

Candidate: concept label1 source documents3 linked claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The chronic chemogenetic toolbox refers to the long-term-use chemogenetic capability discussed in the review. It is framed as promising but currently constrained by unresolved biological and practical hurdles.

Source 1DOIPubMed

What problem it solves

It is intended to enable repeated, long-term neuromodulation experiments and potentially support clinical translation.

Source 1DOIPubMed

What it does not solve

The abstract indicates that the toolbox is not yet fully unlocked because chronic-use discrepancies and hurdles remain to be explained.

Source 1DOIPubMed

Evidence Snippets

Deciphering the underlying cellular and molecular causes of these discrepancies could truly unlock the chronic chemogenetic toolbox and possibly even pave the way for chemogenetics towards clinical application.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1interpretation cautionsupports2022Source 1DOIPubMed

Effects of acute neuromodulation cannot be extrapolated to chronic chemogenetic experiments.

Quoted textsource-backed
It becomes increasingly clear that chronic neuromodulation warrants caution and that the effects of acute neuromodulation cannot be extrapolated towards chronic experiments.
Claim 2limitationsupports2022Source 1DOIPubMed

Chronic chemogenetic application has uncovered various hurdles.

Quoted textsource-backed
Unfortunately, together with the rising number of studies, various hurdles have also been uncovered, especially in relation to its chronic application.
Claim 3mechanistic rationalesupports2022Source 1DOIPubMed

Understanding the cellular and molecular causes of discrepancies between acute and chronic neuromodulation could unlock the chronic chemogenetic toolbox and support clinical application.

Quoted textsource-backed
Deciphering the underlying cellular and molecular causes of these discrepancies could truly unlock the chronic chemogenetic toolbox and possibly even pave the way for chemogenetics towards clinical application.